ES440110A1 - Procedimiento para la obtencion de compuestos esteroides cardiotonicos. - Google Patents

Procedimiento para la obtencion de compuestos esteroides cardiotonicos.

Info

Publication number
ES440110A1
ES440110A1 ES440110A ES440110A ES440110A1 ES 440110 A1 ES440110 A1 ES 440110A1 ES 440110 A ES440110 A ES 440110A ES 440110 A ES440110 A ES 440110A ES 440110 A1 ES440110 A1 ES 440110A1
Authority
ES
Spain
Prior art keywords
formula
see formula
groups
hydrogen
esterified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES440110A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siphar SA
Original Assignee
Siphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar SA filed Critical Siphar SA
Publication of ES440110A1 publication Critical patent/ES440110A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES440110A 1974-08-08 1975-08-08 Procedimiento para la obtencion de compuestos esteroides cardiotonicos. Expired ES440110A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1085574A CH621803A5 (OSRAM) 1974-08-08 1974-08-08

Publications (1)

Publication Number Publication Date
ES440110A1 true ES440110A1 (es) 1977-02-16

Family

ID=4367535

Family Applications (1)

Application Number Title Priority Date Filing Date
ES440110A Expired ES440110A1 (es) 1974-08-08 1975-08-08 Procedimiento para la obtencion de compuestos esteroides cardiotonicos.

Country Status (12)

Country Link
US (1) US4000125A (OSRAM)
JP (1) JPS5141372A (OSRAM)
AR (1) AR217617A1 (OSRAM)
BE (1) BE832271A (OSRAM)
CA (1) CA1049499A (OSRAM)
CH (1) CH621803A5 (OSRAM)
DE (1) DE2534981A1 (OSRAM)
DK (1) DK139101B (OSRAM)
ES (1) ES440110A1 (OSRAM)
FR (1) FR2281124A1 (OSRAM)
GB (1) GB1484655A (OSRAM)
SE (1) SE418401B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144136B (it) * 1980-03-05 1986-10-29 Zenyaku Kogyo Kk Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione
US5373095A (en) * 1985-10-18 1994-12-13 The Upjohn Company Steroid compounds
IT1262931B (it) * 1992-01-16 1996-07-22 Zambon Spa Composti steroidei 17(piridazin-n-ossido)-sostituiti attivi sul sistema cardiovascolare
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
US20100047338A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
EA019560B1 (ru) * 2005-03-02 2014-04-30 Юнивесити Оф Мэриленд, Балтимор Способ лечения простаты (варианты)
WO2009114658A2 (en) * 2008-03-12 2009-09-17 University Of Maryland, Baltimore Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer
GB2470700B (en) 2008-03-25 2012-08-08 Univ Maryland C-17 heteroaryl steroidal CYP17 inhibitors
US8785423B2 (en) * 2008-04-14 2014-07-22 University Of Maryland, Baltimore Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases
ES2552087T3 (es) 2009-02-05 2015-11-25 Tokai Pharmaceuticals, Inc. Nuevos profármacos de inhibidores de CYP17 esteroidales/antiandrógenos
GB2479693B (en) 2009-02-05 2014-04-09 Tokai Pharmaceuticals Inc Steroidal CYP17 inhibitors and their use in the treatment of cancer and prostate hyperplasia
EP2461814A4 (en) 2009-08-07 2012-12-05 Tokai Pharmaceuticals Inc PROSTATE CANCER TREATMENT
US9884067B2 (en) 2013-03-14 2018-02-06 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
US9808472B2 (en) 2013-08-12 2017-11-07 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
EP3313858B1 (en) * 2015-06-29 2019-09-25 Universiteit Gent Methods for the site-selective coupling of a first agent to a second agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838163A (en) * 1968-11-22 1974-09-24 Hoffmann La Roche Substituted isoxazole derivatives as steroid intermediates

Also Published As

Publication number Publication date
DK139101C (OSRAM) 1979-05-21
DE2534981A1 (de) 1976-02-19
DK139101B (da) 1978-12-18
CA1049499A (en) 1979-02-27
GB1484655A (en) 1977-09-01
SE418401B (sv) 1981-05-25
AR217617A1 (es) 1980-04-15
SE7508908L (sv) 1976-02-09
BE832271A (fr) 1975-12-01
DK358875A (OSRAM) 1976-02-09
CH621803A5 (OSRAM) 1981-02-27
FR2281124A1 (fr) 1976-03-05
JPS5141372A (OSRAM) 1976-04-07
FR2281124B1 (OSRAM) 1980-05-16
US4000125A (en) 1976-12-28

Similar Documents

Publication Publication Date Title
ES440110A1 (es) Procedimiento para la obtencion de compuestos esteroides cardiotonicos.
Sears et al. Structure of catechinic acid. Base rearrangement product of catechin
Stevens et al. Elaiomycin. 1 an aliphatic α, β-unsaturated azoxy compound
SE323866B (OSRAM)
ES366943A1 (es) Procedimiento para la preparacion de derivados de 1-etil-3,3-dimetil-ciclohexano.
ES301833A1 (es) Un procedimiento para la prepación de 19-alkil-esteroides
ES8308826A1 (es) Un metodo de preparar quinonas.
ES396473A1 (es) Procedimiento para la preparacion de derivados de isoindo- lina.
ES429020A1 (es) Procedimiento para preparar nuevos derivados de tiazol-5- metanol.
ES404744A1 (es) Un procedimiento para producir derivados de cefalosporina.
US3159622A (en) 17 alpha-(2-carboxyethyl)-17 belta-hydroxy-6-nitroandrost-4-en-3-one gamma-lactones
US2320847A (en) delta 5-cholestenone-3 and a method for producing the same
US2522177A (en) Ethers of 16-keto-(alpha) estradiol and method of manufacturing the same
Wolfrom et al. Degradative studies on streptomycin
HU184706B (en) Process for preparing labelled gibberellines
US3128291A (en) New hemiacetals and hemicaetal esters of the androstane series and a method for their production
GB1324048A (en) Process and catalyst for the polymerization of conjugated dienes
US3176012A (en) Novel 21-bis-(hydroxymethyl)-5beta-pregnanes and their preparation
ES421790A1 (es) Procedimiento de preparacion de derivados del acido prosta-noico.
Sugiyama et al. The Photoreaction of p-Substituted β-Benzoylacrylic Acids
ES384331A1 (es) Procedimiento para la obtencion de 6 alfa-metil-19-nor- progesterona.
ES376027A1 (es) Un procedimiento para la preparacion de nuevos 3-desoxo-19-nor-esteroides.
ES428225A1 (es) Procedimiento para la preparacion de 17 beta-oxalil-este- roides.
ES376501A1 (es) Procedimiento de preparacion de nuevos acetales ciclicos derivados del pregnano.
KR790001072B1 (ko) 피리도 [3, 4-d] 피리다진류의 제조법